Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1846-1848

  Jung, Gundram ^a   Grosse Hovest, Ludger ^a   Krammer, Peter H ^b   Rammensee, Hans Georg ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CD95 DEATH RECEPTOR; CELL SURFACE RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN TARGETING;

ANTIBODIES, BISPECIFIC; ANTIGENS, CD20; ANTIGENS, CD95; APOPTOSIS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; JURKAT CELLS; LYMPHOMA, B-CELL;

EID: 0035266408     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bispecific antibodies in cancer therapy
2. Selective stimulation of human T lymphocyte subsets by heteroconjugates of antibodies to the T cell receptor and to subset-specific differentiation antigens
3. T cell activation by a bispecific anti-CD3/anti-major histocompatibility complex class I antibody
4. Target cell induced T cell activation with bi- and trispecific antibody fragments
5. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
6. Monoclonal antibody mediated tumor regression by induction of apoptosis
7. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross linking of APO-1 cell surface antigens
8. Lethal effect of the anti-Fas antibody in mice
9. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody
10. A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity
11. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies
12. CD40 ligation induces APO-1/Fas expression on human B lymphocytes and facilitates apoptosis through the APO-1/Fas pathway
13. Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
14. CD28 and apoptosis
15. Gp96, the immune system's Swiss army knife
16. Building better vaccines: How apoptotic cell death can induce inflammation and activate innate and adaptive immunity